Ring Therapeutics
Revolutionizing Medicine with Commensal Viruses
Cambridge, United States · Founded 2017 · $203.5M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- ringtx.com
- Total Funding
- $203.5M
- Last Round
- $86.5M Series CMar 2023
- Rounds
- 2
About
Ring Therapeutics, founded by Flagship Pioneering in 2017, is developing a novel gene therapy platform based on anelloviruses — commensal human viruses. Programmable, redosable DNA medicines.
Summary
Ring Therapeutics is a Biotech company based in Cambridge, United States, founded in 2017. It has raised $203.5M in total across 2 rounds, most recently a $86.5M Series C round in Mar 2023. Investors include Flagship Pioneering, Alexandria Venture Investments and Altitude Life Science Ventures.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.